This correction allows for a sustainable improvement in vitality, rather than just a fleeting sensation
It is often sold alongside research peptides because it fits the same metabolic research space, but chemically it is closer to a small-molecule drug than to peptides like BPC-157 or semaglutide
First study author Michael Corley, PhD, associate professor of medicine in the Division of Geriatrics, Gerontology & Palliative Care at UC San Diego School of Medicine and the Stein Institute for Research on Aging, spoke to Medical News Today about the study findings
Scientific studies have demonstrated its ability to promote angiogenesis (the formation of new blood vessels) and upregulate growth factors essential for wound healing
The drug has now been okayed in the US for chronic lymphocytic leukemia (CLL), where the bone marrow makes too many of certain white blood cells
Biochim Biophys Acta Gen Subj 1770:902911